Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-009711
Filing Date
2025-05-12
Accepted
2025-05-12 16:30:14
Documents
4
Period of Report
2025-05-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm PRE 14A 1018482
2 GRAPHIC formpre14a_001.jpg GRAPHIC 12922
3 GRAPHIC formpre14a_002.jpg GRAPHIC 12922
4 GRAPHIC formpre14a_003.jpg GRAPHIC 12922
  Complete submission text file 0001641172-25-009711.txt   1073532
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40789 | Film No.: 25935318
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)